Trials / Terminated
TerminatedNCT00454402
ALF-STONE: Alfuzosin in Uretheric Stones
Alfuzosin in Uretheric Stones
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- Sponsor
- Sanofi · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to assess the effect of Alfuzosin compared with placebo, for 7 days, on the outcome of patients with uretheric stones submitted to Extracorporeal Shock Wave Lithotripsy (ESWL), namely in the percentage of patients without imagiologic evidence of any stone after 72h to 96 hours. This study will also specifically focus on the evaluation of time of stone clearance and of pain reduction (Numeric Rating Scale).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alfuzosin |
Timeline
- Start date
- 2006-08-01
- Completion
- 2007-07-01
- First posted
- 2007-03-30
- Last updated
- 2007-09-24
Locations
1 site across 1 country: Portugal
Source: ClinicalTrials.gov record NCT00454402. Inclusion in this directory is not an endorsement.